Delivery Order SPE2DB22D2206-SPE2DB23FJX37
Award Date 8/22/23
Potential Completion Date 9/13/23
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $15,953.54 delivery order to AmerisourceBergen Drug Corp for FOTIVDA 1.34 mg capsule supply (21-count units) on August 4, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price contract is not set-aside and represents a competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery will be performed at...
- The Defense Logistics Agency awarded a $15,953.54 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for FOTIVDA 1.34 mg capsules (21-count). This contract, which is non-set-aside and competitively awarded, is structured as a firm fixed price delivery order with a completion date of August 21, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of FOTIVDA 0.89 mg capsules (21 count), with a ceiling value of $32,270.40 and a firm fixed price structure. This non-set-aside delivery order is scheduled for completion by September 12, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $31,192.36 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561598368 FOTIVDA 0.89 MG CAPSULE 21S. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will deliver the requested pharmaceutical products to a location in Conshohocken, Pennsylvania by August 15, 2023. As a major component of the Department of Defense that manages global logistics operations for the military services, the Defense...
- The Defense Logistics Agency awarded a $30,841 delivery order to Amerisourcebergen Drug Corporation for FOTIVDA 1.34 MG CAPSULE 21S. The firm fixed price order is being performed in Conshohocken, Pennsylvania under DLA's Pharmaceutical Prime Vendor contract vehicle, which provides pharmaceuticals and other medical commodities to support various DOD programs. No set aside designation or subcontractors were indicated. The order runs from September 27, 2023 through October 19, 2023 and will deliver...
- The Defense Logistics Agency awarded a $15,953.54 delivery order to AmerisourceBergen Drug Corp for Fotivda 1.34 mg capsules (21-count units) under a firm fixed-price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by September 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $31,907.08 to AmerisourceBergen Drug Corp for FOTIVDA (tivozanib) 1.34 mg capsules (21-count units) on August 21, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- This is a firm fixed-price delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $32,270.40, is for the delivery of FOTIVDA 0.89 MG CAPSULE 21S, a specialty pharmaceutical product. The contract has an ultimate completion date of December 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, through its Corporate Office division, to provide FOTIVDA 0.89 MG CAPSULE 21S, a specialty pharmaceutical product, with a ceiling value of $32,652.72 and a performance period through April 25, 2024. The award is a firm fixed price contract and does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor and serves as a key supplier of pharmaceuticals and medical...
- The Defense Logistics Agency awarded a $7,940.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 capsules of Tafinlar, a cancer treatment medication. As the prime contractor, Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania by October 13, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to ensure medical supplies are available to support military readiness and...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FJX37Delivery Order
The Defense Logistics Agency awarded a delivery order under an undisclosed contract vehicle to AmerisourceBergen Drug Corporation for the supply of 21 capsules of the pharmaceutical FOTIVDA at 0.89 mg each. Valued at $15,596.18 with a firm fixed price, the order is to be performed in Conshohocken, Pennsylvania between August 22nd and September 13th, 2023. As a major provider of medical supplies and pharmaceuticals to the U.S. military, this order for cancer treatment medication supports the Defense Logistics Agency's mission to provide critical healthcare resources and logistical support to all branches of the armed forces. No subcontractors or set-aside designations were indicated.
Generated 12/20/23, 1:45 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.6k | 8/22/23 |